Upgrade to SI Premium - Free Trial

Form 3/A Calithera Biosciences, For: Jan 01 Filed by: Parlati Francesco

March 6, 2018 4:09 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Parlati Francesco
(Last) (First) (Middle)
C/O CALITHERA BIOSCIENCES, INC.
343 OYSTER POINT BLVD. #200
(Street)
SOUTH SAN FRANCISCO CA 94080
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2017 		3. Issuer Name and Ticker or Trading Symbol
Calithera Biosciences, Inc. [ CALA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, RESEARCH
 5. If Amendment, Date of Original Filed (Month/Day/Year)
01/06/2017
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 20,349 (1)
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
STOCK OPTION (RIGHT TO BUY) (2) 05/22/2023 COMMON STOCK 1,979 0.96 D
STOCK OPTION (RIGHT TO BUY) (3) 05/22/2023 COMMON STOCK 3,116 0.96 D
STOCK OPTION (RIGHT TO BUY) (4) 12/16/2023 COMMON STOCK 6,246 2.64 D
STOCK OPTION (RIGHT TO BUY) (5) 09/08/2024 COMMON STOCK 5,688 7.2 D
STOCK OPTION (RIGHT TO BUY) (6) 02/10/2025 COMMON STOCK 7,000 16.4 D
STOCK OPTION (RIGHT TO BUY) (7) 01/18/2026 COMMON STOCK 12,000 4.71 D
STOCK OPTION (RIGHT TO BUY) (8) 11/28/2026 COMMON STOCK 25,000 3.35 D
Explanation of Responses:
1. 7,967 shares were omitted from the Reporting Person's original Form 3, and also were omitted from one Form 4 filed by the Reporting Person after his original Form 3 was filed.
2. One-forty-eighth (l/48th) of the Option vests in equal monthly installments beginning November 15, 2012. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
3. One- forty-eighth (l/48th) of the Option vests in equal monthly installments one month after May 23, 2013. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
4. One-forty-eighth (l/48th) of the Option vests in equal monthly installments one month after December 17, 2013. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
5. One-forty-eighth (1/48th) of the Option vests in equal monthly installments one month after September 9, 2014. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
6. One-fourth (1/4th) of the Option vests one year after February 11, 2015; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
7. One-fourth (1/4th) of the Option vests one year after January 19, 2016; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
8. One-fourth (1/4th) of the Option vests one year after November 29, 2016; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
/s/ Francesco Parlati, Name: Francesco Parlati 03/06/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings